Purchase Order 75N92019P00078

<p>The National Heart Lung and Blood Institute issued a purchase order to Becton, Dickinson and Company (Infectious Disease Systems division) on February 28, 2018, with a ceiling value of $32,562.00 for maintenance services. The order is firm fixed price with no small business set-aside. Place of performance is Bethesda, Maryland. The ultimate completion date is March 14, 2019.</p>

Becton, Dickinson and Company (BD) was awarded a firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health's National Heart, Lung and Blood Institute to provide maintenance services for a BD Biosciences Fortessa flow cytometer. The potential value of this contract is $147,863.40. No set-aside designation was used for this award. Performance will occur in Bethesda, Maryland and continue through January 31, 2025. This award is associated with the...

This firm fixed price purchase order for $270,406.20 was awarded by the Department of Health and Human Services' National Institutes of Health National Heart, Lung and Blood Institute to Becton, Dickinson and Company for maintenance services. The place of performance is Bethesda, Maryland and the period of performance runs through May 31, 2022. No set-aside designation was used for this solicitation. Becton, Dickinson and Company will deliver these services through their BD Biosciences...

The National Heart Lung and Blood Institute awarded a purchase order to Becton, Dickinson and Company (BD Biosciences) for an LSRFortessa multi-year maintenance agreement with a ceiling value of $283,987.80, awarded November 17, 2014, with ultimate completion November 20, 2019. Place of performance is Bethesda, Maryland. The order is firm fixed price with no set-aside. This is a maintenance agreement supporting flow cytometry instrumentation at a federal research facility, typical of BD...

The Department of Health and Human Services' National Institutes of Health's National Heart Lung and Blood Institute awarded a $265,954.69 firm fixed price purchase order to Becton, Dickinson and Company for a FACS Melody Cell Sorter. BD Biosciences, a division of BD, will provide the cell sorting instrument as the prime contractor. The place of performance is in San Jose, California and the period of performance completion date is January 29, 2021. No set-aside designation was used for this...

<p>The National Heart, Lung, and Blood Institute (NHLBI) awarded a purchase order to Becton, Dickinson and Company (BD Biosciences) for $17,550.00 on June 2, 2026, for service contract support of a BD Symphony A1 flow cytometer. Performance is at Framingham, Massachusetts. The order is firm fixed price with a completion date of June 1, 2027. No small business set-aside applies.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to Becton, Dickinson and Company (BD Biosciences) valued at $597,605.36 on September 10, 2018, for BD FACSymphony trade-in and purchase. The order has no small business set-aside. Performance is located in San Jose, California. The ultimate completion date is February 28, 2019. The originating opportunity was posted as a special notice on August 30, 2018.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to Becton, Dickinson and Company for $142,981.11 on March 27, 2013, for service on an LSR II Special flow cytometer system (no lasers). Performance is located in Bethesda, Maryland. The order is firm fixed price with an ultimate completion date of April 2, 2018.</p>

<p>The National Heart Lung and Blood Institute issued a delivery order to Becton, Dickinson and Company on November 6, 2018, with a ceiling value of $13,115.28 for facility control and facilities services at the National Heart Lung and Blood Institute in Bethesda, Maryland.</p> <p>Place of performance is Bethesda, MD 20892. The order is firm fixed price with an ultimate completion date of November 17, 2019. No set-aside was used.</p>

The National Heart Lung and Blood Institute issued a $13,115.28 delivery order to Becton, Dickinson and Company (BD Biosciences) on December 20, 2017, with an ultimate completion date of November 17, 2018. This is a firm fixed-price delivery order placed under the GSA Scientific Equipment and Services Schedule (FSS-66). Place of performance is Bethesda, MD. The order was issued without a set-aside. BD Biosciences supplies flow cytometry systems, reagents, and related biomedical research...